Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with maternal serum bile acid profiles

Background Intrahepatic cholestasis of pregnancy (ICP) is associated with increased risk of adverse perinatal outcomes, yet current monitoring lacks predictive accuracy. This study aimed to explore alterations in serum bile acid profiles and their relationship with adverse perinatal outcomes in ICP.Methods This study enrolled 149 pregnant women, including 77 normal pregnant women and 72 cases with ICP, subdivided into ICP with adverse perinatal outcomes and those without according to the perinatal outcomes. Serum concentrations of 15 bile acids were quantified using ultra-performance liquid chromatography-tandem mass spectrometry and compared among the three groups.Results ICP patients exhibited significantly lower gestational age at delivery, Apgar scores, and birth weight, alongside higher rates of cesarean delivery, low birth weight, neonatal intensive care unit admission, meconium-stained amniotic fluid, and preterm birth (all p < 0.05). Twelve bile acids were significantly elevated in ICP (all p < 0.01); notably, taurolithocholic acid elevation was exclusive to the ICP with adverse perinatal outcomes. Glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), taurocholic acid (TCA), taurochenodeoxycholic acid (TCDCA), tauroursodeoxycholic acid (TUDCA), and total bile acid levels positively correlated with adverse perinatal outcomes (all p < 0.05). The combined indicator of these six indicators demonstrated superior predictive efficacy for adverse perinatal outcomes with an area under the curve of 0.836, sensitivity of 73.0%, and specificity of 82.9%.Conclusions Distinct serum bile acid metabolic signatures characterize ICP patients with adverse perinatal outcomes. Elevated levels of total bile acids and conjugated bile acids, including GCA, GCDCA, TCA, TCDCA, and TUDCA, were associated with adverse perinatal outcomes and might serve as candidate biomarkers for risk prediction. The multi-bile acid combined indicator demonstrated superior exploratory predictive performance over individual markers, offering a potential tool for identifying high-risk ICP patients, which requires prospective external validation before clinical application.

Authors

Institutions

Publication Details

Journal
Annals of Medicine
Published
2026-11-18
DOI
https://doi.org/10.1080/07853890.2026.2762407
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with maternal serum bile acid profiles

Lingshan Gou, Bulian Dong, Sijia Gao, 王巧莲 et al.
Annals of Medicine
Pregnancy and preeclampsia studies
article

Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with maternal serum bile acid profiles

Lingshan Gou, Bulian Dong, Sijia Gao, 王巧莲, Zhen Wang, Feng Suo, Maosheng Gu, Xin Yin, Xinyu Wu, Fei Liu, Jie Liu, Daoyan Liu
article en

Abstract

Background Intrahepatic cholestasis of pregnancy (ICP) is associated with increased risk of adverse perinatal outcomes, yet current monitoring lacks predictive accuracy. This study aimed to explore alterations in serum bile acid profiles and their relationship with adverse perinatal outcomes in ICP.Methods This study enrolled 149 pregnant women, including 77 normal pregnant women and 72 cases with ICP, subdivided into ICP with adverse perinatal outcomes and those without according to the perinatal outcomes. Serum concentrations of 15 bile acids were quantified using ultra-performance liquid chromatography-tandem mass spectrometry and compared among the three groups.Results ICP patients exhibited significantly lower gestational age at delivery, Apgar scores, and birth weight, alongside higher rates of cesarean delivery, low birth weight, neonatal intensive care unit admission, meconium-stained amniotic fluid, and preterm birth (all p < 0.05). Twelve bile acids were significantly elevated in ICP (all p < 0.01); notably, taurolithocholic acid elevation was exclusive to the ICP with adverse perinatal outcomes. Glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), taurocholic acid (TCA), taurochenodeoxycholic acid (TCDCA), tauroursodeoxycholic acid (TUDCA), and total bile acid levels positively correlated with adverse perinatal outcomes (all p < 0.05). The combined indicator of these six indicators demonstrated superior predictive efficacy for adverse perinatal outcomes with an area under the curve of 0.836, sensitivity of 73.0%, and specificity of 82.9%.Conclusions Distinct serum bile acid metabolic signatures characterize ICP patients with adverse perinatal outcomes. Elevated levels of total bile acids and conjugated bile acids, including GCA, GCDCA, TCA, TCDCA, and TUDCA, were associated with adverse perinatal outcomes and might serve as candidate biomarkers for risk prediction. The multi-bile acid combined indicator demonstrated superior exploratory predictive performance over individual markers, offering a potential tool for identifying high-risk ICP patients, which requires prospective external validation before clinical application.

Annals of MedicineVol. 58(1)
Xuzhou Medical College (CN), Maternal and Child Health Hospital of Xuzhou (CN)
Government of Jiangsu Province
Good health and well-being
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon